TY - GEN AU - Kim,Nayoung AU - Cho,Ahye AU - Watanabe,Hideo AU - Choi,Yoon-La AU - Aziz,Meraj AU - Kassner,Michelle AU - Joung,Je-Gun AU - Park,Angela Kyung-Joo AU - Francis,Joshua M AU - Bae,Joon Seol AU - Ahn,Soo-Min AU - Kim,Kyoung-Mee AU - Park,Joon Oh AU - Park,Woong-Yang AU - Ahn,Myung-Ju AU - Park,Keunchil AU - Koo,Jaehyung AU - Yin,Hongwei Holly AU - Cho,Jeonghee TI - Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation SN - 1949-2553 PY - 2017///1218 KW - Animals KW - Apoptosis KW - Biomarkers, Tumor KW - genetics KW - Carcinogenesis KW - Carcinoma, Non-Small-Cell Lung KW - drug therapy KW - Cell Proliferation KW - Drug Resistance, Neoplasm KW - ErbB Receptors KW - antagonists & inhibitors KW - Erlotinib Hydrochloride KW - pharmacology KW - Genomics KW - methods KW - Humans KW - Lung Neoplasms KW - Male KW - Mice KW - Mice, Nude KW - Mutation KW - Nerve Tissue Proteins KW - Protein Kinase Inhibitors KW - RNA, Small Interfering KW - Signal Transduction KW - Tumor Cells, Cultured KW - Xenograft Model Antitumor Assays N1 - Publication Type: Journal Article UR - https://doi.org/10.18632/oncotarget.7318 ER -